Ethical aspects of tissue engineering: A review

Tissue Engineering - Part B: Reviews

Volumn 14, Issue 4, 2008, Pages 367-375

  De Vries, Rob B M ^a   Oerlemans, Anke ^a   Trommelmans, Leen ^b   Dierickx, Kris ^b   Gordijn, Bert ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY STAGES; ETHICAL ASPECTS; ETHICAL ISSUES; ETHICAL QUESTIONS; HUMAN EMBRYONIC STEM CELLS; MEDICAL TECHNOLOGIES; NEW TECHNOLOGIES; SCIENTIFIC LITERATURES;

CLONING; GENETIC ENGINEERING;

TISSUE ENGINEERING;

ALTRUISM; CELL DIFFERENTIATION; CLINICAL PRACTICE; CLONING; DONOR; EMBRYONIC STEM CELL; FETUS CELL; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; MORALITY; PRIORITY JOURNAL; PRIVACY; RESEARCH ETHICS; REVIEW; TISSUE ENGINEERING; UMBILICAL CORD BLOOD; XENOGRAFT;

ALTRUISM; ANIMALS; CLINICAL TRIALS AS TOPIC; CLONING, ORGANISM; EMBRYONIC STEM CELLS; ETHICS, MEDICAL; HUMANS; INFORMED CONSENT; PERIODICALS AS TOPIC; RESEARCH; TISSUE AND ORGAN PROCUREMENT; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 56749106377     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2008.0199     Document Type: Review

References (159)

1. Langer, R., and Vacanti, J.P. Tissue Engineering. Science 260, 920, 1993.
2. Bock, A.-K., Ibaretta, D., and Rodriguez-Cerezo, E. Human Tissue-Engineered Products. Today's Markets and Future Prospects. JRC-IPTS, 2003.
3. Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group (IWG). Advancing tissue science and engineering: a foundation for the future, p.3, 2007.
4. Cogle, C.R., Guthrie, S.M., Sanders, R.C., Allen, W.L., Scott, E.W., and Petersen, B.E. An overview of stem cell research and regulatory issues. Mayo Clin Proc 78, 993, 2003.
5. Cooper, M. Regenerative medicine: stem cells and the science of monstrosity. Med Humanit 30, 12, 2004.
6. Daar, A.S., Bhatt, A., Court, E., and Singer, P.A. Stem cell research and transplantation: science leading ethics. Transplant Proc 36, 2504, 2004.
7. Denker, H. Embryonic stem cells: an exciting field for basic research and tissue engineering, but also an ethical dilemma? Cells Tissues Organs 165, 246, 1999.
8. Dickens, B.M., and Cook, R.J. Acquiring human embryos for stem cell research. Int J Gynaecol Obstet 96, 67, 2007.
9. Fischbach, G.D., and Fischbach, R.L. Stem cells: science, policy, and ethics. J Clin Invest 114, 1364, 2004.
10. Henon, P.R. Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering. Adv Exp Med Biol 534, 27, 2003.
11. Holm, S. Are countries that ban human embryonic stem cell research hypocritical? Regen Med 1, 357, 2006.
12. Hug, K. Therapeutic perspectives of human embryonic stem cell research versus the moral status of a human embryo - does one have to be compromised for the other? Medicina (Kaunas) 42, 107, 2006.
13. Resnik, D.B. The commercialization of human stem cells: ethical and policy issues. Health Care Anal 10, 127, 2002.
14. Solbakk, J.H. Stem cell research and the ethics of transparency. Regen Med 1, 831, 2006.
15. Sulmasy, D.P. Promethean medicine: spirituality, stem cells, and cloning. South Med J 99, 1419, 2006.
16. Tsang, L. Legal and ethical status of stem cells as medicinal products. Adv Drug Deliv Rev 57, 1970, 2005.
17. Yoshimura, Y. Bioethical aspects of regenerative and reproductive medicine. Human Cell 19, 83, 2006.
18. Zwanziger, L.L. Biology, ethics, and public policy: deliberations at an unstable intersection. Anat Rec B New Anat 275, 185, 2003.
19. Bongso, A., and Richards, M. History and perspective of stem cell research. Best Pract Res Clin Obstet Gynaecol 18, 827, 2004.
20. Choumerianou, D.M., Dimitriou, H., and Kalmanti, M. Stem cells: promises versus limitations. Tissue Eng Part B Rev 14, 53, 2008.
21. Cortes, J.L., Cobo, F., Barnie, A.H., Catalina, P., Cabrera, C., Nieto, A., Montes, R., and Concha, A. Role of the embryology laboratory in the human embryonic stem cell line derivation process. Cytotechnology 52, 1, 2006.
22. du Toit, D. Stem cell research. SADJ 61, 334, 2006.
23. Findikli, N., Candan, N.Z., and Kahraman, S. Human embryonic stem cell culture: current limitations and novel strategies. Reprod Biomed Online 13, 581, 2006.
24. Garner, J.P. Tissue engineering in surgery. Surgeon 2, 70, 2004.
25. Gudjonsson, T., Thomsen, A.R., Vainio, O., and Ogmundsdottir, H.M. Stem cells. APMIS 113, 725, 2005.
26. Jain, K.K. Stem cell technologies in regenerative medicine. Expert Opin Biol Ther 2, 771, 2002.
27. Jell, G. Stem cells in regenerative medicine. Pharm J 275, 73, 2005.
28. Kansu, E. Current views on stem cell biology and plasticity. Turk J Cancer 33, 69, 2003.
29. Lerou, P.H., and Daley, G.Q. Therapeutic potential of embryonic stem cells. Blood Rev 19, 321, 2005.
30. Lo, K.C., Whirledge, S., and Lamb, D.J. Stem cells: implications for urology. Curr Urol Rep 6, 49, 2005.
31. Mummery, C. Stem cell research: immortality or a healthy old age? Eur J Endocrinol 151 Suppl 3, 7, 2004.
32. Polak, J.M., and Bishop, A.E. Stem cells and tissue engineering: past, present, and future. Ann NY Acad Sci 1068, 352, 2006.
33. Reed, J.A., and Patarca, R. Regenerative dental medicine: stem cells and tissue engineering in dentistry. J Environ Pathol Toxicol Oncol 25, 537, 2006.
34. Reubinoff, B. Current status of human embryonic stem cell research. Reprod Biomed Online 14, 121, 2007.
35. Rippon, H.J., and Bishop, A.E. Embryonic stem cells. Cell Prolif 37, 23, 2004.
36. Rodriguez, C., and Simon, C. Human embryonic stem cell derivation: from the IVF perspective to therapeutic applications. Regen Med 1, 103, 2006.
37. Sadiq, T.S., and Gerber, D.A. Stem cells in modern medicine: reality or myth? J Surg Res 122, 280, 2004.
38. Sievert, K.D., Amend, B., and Stenzl, A. Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 52, 1580, 2007.
39. Stoltz, J.F., Bensoussan, D., Decot, V., Ciree, A., Netter, P., and Gillet, P. Cell and tissue engineering and clinical applications: an overview. Biomed Mater Eng 16, S3, 2006.
40. Sylvester, K.G., and Longaker, M.T. Stem cells: review and update. Arch Surg 139, 93, 2004.
41. Turksen, K., and Troy, T.C. Human embryonic stem cells: isolation, maintenance, and differentiation. Methods Mol Biol 331, 1, 2006.
42. Vats, A., Bielby, R.C., Tolley, N.S., Nerem, R., and Polak, J.M. Stem cells. Lancet 366, 592, 2005.
43. Weissman, I. Stem cell research: paths to cancer therapies and regenerative medicine. JAMA 294, 1359, 2005.
44. Wobus, A.M., and Boheler, K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85, 635, 2005.
45. Ballas, C.B., Zielske, S.P., and Gerson, S.L. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 38, 20, 2002.
46. Körbling, M., Estrov, Z., and Champlin, R. Adult stem cells and tissue repair. Bone Marrow Transplant 32 Suppl 1, S23, 2003.
47. Krampera, M., Pizzolo, G., Aprili, G., and Franchini, M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39, 678, 2006.
48. Markowicz, M., Heitland, A., Steffens, G.C.M., Neuss, S., and Pallua, N. Human mesenchymal stem cell implantation and collagen modification as a tool for tissue engineering. Eur J Plast Surg 28, 284, 2005.
49. Tögel, F., and Westenfelder, C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 236, 3321, 2007.
50. Fauza, D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18, 877, 2004.
51. Perin, L., Giuliani, S., Jin, D., Sedrakyan, S., Carraro, G., Habibian, R., Warburton, D., Atala, A., and de Filippo, R.E. Renal differentiation of amniotic fluid stem cells. Cell Prolif 40, 936, 2007.
52. Prusa, A.R., Marton, E., Rosner, M., Bernaschek, G., and Hengstschlager, M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18, 1489, 2003.
53. Igura, K., Zhang, X., Takahashi, K., Mitsuru, A., Yamaguchi, S., and Takashi, T.A. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 6, 543, 2004.
54. Katz-Benichou, G. Umbilical cord blood banking: economic and therapeutic challenges. Int J Healthc Technol Manage 8, 464, 2007.
55. Parolini, O., Alviano, F., Bagnara, G.P., Bilic, G., Buhring, H.J., Evangelista, M., Hennerbichler, S., Liu, B., Magatti, M., Mao, N., Miki, T., Marongiu, F., Nakajima, H., Nikaido, T., Portmann-Lanz, C.B., Sankar, V., Soncini, M., Stadler, G., Surbek, D., Takahashi, T.A., Redl, H., Sakuragawa, N., Wolbank, S., Zeisberger, S., Zisch, A., and Strom, S.C. Isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26, 300, 2008.
56. Yen, B.L., Chien, C.C., Chen, Y.C., Chen, J.T., Huang, J.S., Lee, F.K., and Huang, H.I. Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng Part A 14, 9, 2008.
57. Goldberg, J.L., Laughlin, M.J., and Pompili, V.J. Umbilical cord blood stem cells: implications for cardiovascular regenerative medicine. J Mol Cell Cardiol 42, 912, 2007.
58. Harris, D.T., Badowski, M., Ahmad, N., and Gaballa, M.A. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther 7, 1311, 2007.
59. Lee, M.W., Yang, M.S., Park, J.S., Kim, H.C., Kim, Y.J., and Choi, J. Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood. Int J Hematol 81, 126, 2005.
60. McGuckin, C.P., Forraz, N., Baradez, M.O., Navran, S., Zhao, J., Urban, R., Tilton, R., and Denner, L. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 38, 245, 2005.
61. Wang, H.S., Hung, S.C., Peng, S.T., Huang, C.C., Wei, H.M., Guo, Y.J., Fu, Y.S., Lai, M.C., and Chen, C.C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22, 1330, 2004.
62. Weiss, M.L., and Troyer, D.L. Stem cells in the umbilical cord. Stem Cell Rev 2, 155, 2006.
63. Alberio, R., Campbell, K.H., and Johnson, A.D. Reprogramming somatic cells into stem cells. Reproduction 132, 709, 2006.
64. Cai, S., Fu, X.B., and Sheng, Z.Y. Dedifferentiation: a new approach in stem cell research. Bioscience 57, 655, 2007.
65. Collas, P., and Gammelsaeter, R. Novel approaches to epigenetic reprogramming of somatic cells. Cloning Stem Cells 9, 26, 2007.
66. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B.E., and Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318, 2007.
67. Chung, Y., Klimanskaya, I., Becker, S., Marh, J., Lu, S.-J., Johnson, J., Meisner, L., and Lanza, R. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439, 216, 2006.
68. Fangerau, H. Can artificial parthenogenesis sidestep ethical pitfalls in human therapeutic cloning? An historical perspective. J Med Ethics 31, 733, 2005.
69. Hipp, J., and Atala, A. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod 1, 3, 2004.
70. Landry, D.W., Zucker, H.A., Sauer, M.V., Reznik, M., and Wiebe, L. Hypocellularity and absence of compaction as criteria for embryonic death. Regen Med 1, 367, 2006.
71. Weissman, I. Politic stem cells. Nature 439, 145, 2006.
72. Zhang, X., Stojkovic, P., Przyborski, S., Cooke, M., Armstrong, L., Lako, M., and Stojkovic, M. Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24, 2669, 2006.
73. Abouna, G.M. Ethical issues in organ transplantation. Med Princ Pract 12, 54, 2003.
74. Lanza, R.P., Cibelli, J.B., and West, M.D. Prospects for the use of nuclear transfer in human transplantation. Nat Biotechnol 17, 1171, 1999.
75. Romano, G. Perspectives and controversies in the field of stem cell research. Drug News Perspect 19, 433, 2006.
76. Dhai, A., Moodley, J., Quoid-Mason, D.J., and Rodeck, C. Ethical and legal controversies in cloning for biomedical research. A South African perspective. S Afr Med J 94, 906, 2004.
77. Hall, V.J., Stojkovic, P., and Stojkovic, M. Using therapeutic cloning to fight human disease: a conundrum or reality? Stem Cells 24, 1628, 2006.
78. Goldspink, G., MacDermot, K.D., and Novo, F.J. Social and moral implications arising from genetic screening and genetic engineering. Med Princ Pract 7, 150, 1998.
79. Lomax, G.P., Hall, Z.W., and Lo, B. Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards. PLoS Med 4, 803, 2007.
80. Thompson, C. Why we should, in fact, pay for egg donation. Regen Med 2, 203, 2007.
81. Awaya, T. Common ethical issues in regenerative medicine. J Int Bioethique 16, 69, 2005.
82. Fiegel, H.C., Lange, C., Kneser, U., Lambrecht, W., Zander, A.R., Rogiers, X., and Kluth, D. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med 10, 577, 2006.
83. Löwenheim, H., Dazert, S., Bucheler, M., and Guntinas-Lichius, O. Regenerative medicine/cellular engineering for diseases of the head and neck. DNA Cell Biol 22, 547, 2003.
84. Baum, B.J., and Mooney, D.J. The impact of tissue engineering on dentistry. J Am Dent Assoc 131, 309, 2000.
85. Enoch, S., Shaaban, H., and Dunn, K.W. Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material. J Med Ethics 31, 2, 2005.
86. Faulkner, A., Kent, J., Geesink, I., and FitzPatrick, D. Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technology. Soc Sci Med 63, 2277, 2006.
87. Garner, J.P. Tissue engineering and the trauma surgeon. Trauma 4, 177, 2002.
88. Hammerman, M.R., and Cortesini, R. Organogenesis and tissue engineering. Transpl Immunol 12, 191, 2004.
89. Iijima, K., Igawa, Y., Imamura, T., Moriizumi, T., Nikaido, T., Konishi, I., and Nishizawa, O. Transplantation of preserved human amniotic membrane for bladder augmentation in rats. Tissue Eng 13, 513, 2007.
90. Kent, J., Faulkner, A., Geesink, I., and FitzPatrick, D. Culturing cells, reproducing and regulating the self. Body Society 12, 1, 2006.
91. Longley, D., and Lawford, P. Engineering human tissue and regulation: confronting biology and law to bridge the gaps. Med Law Int 5, 101, 2001.
92. Nieminen, O., and Kurki, P. Risk management for biological products. Int J Pharm Med 18, 149, 2004.
93. Schwab, I.R., Johnson, N.T., and Harkin, D.G. Inherent risks associated with manufacture of bioengineered ocular surface tissue. Arch Ophthalmol 124, 1734, 2006.
94. Tzanakakis, E.S., Hess, D.J., Sielaff, T.D., and Hu, W.S. Extracorporeal tissue engineered liver-assist devices. Annu Rev Biomed Eng 2, 607, 2000.
95. Black, J. Thinking twice about "tissue engineering". IEEE Eng Med Biol Mag 16, 102, 1997.
96. Bredehorn, T., and Rudolph, B. Legal problems in tissue transplantation. Transplant Proc 34, 2345, 2002.
97. Orr, S., Alexandre, E., Clark, B., Combes, R., Fels, L.M., Gray, N., Jönsson-Rylander, A.-C., Helin, H., Koistinen, J., Oinonen, T., Richert, L., Ravid, R., Salonen, J., Teeslau, T., Thasler, W.E., Trafford, J., van der Valk, J., von Versen, R., Weiss, T., Womack, C., and Ylikomi, T. The establishment of a network of European human research tissue banks. Cell Tissue Bank 3, 133, 2002.
98. Pascal, P., Damour, O., Colpart, J.J., and Braye, F. French legal framework relating to human tissues and cells. Med Biol Eng Comput 38, 241, 2000.
99. Salvaterra, E., Lecchi, L., Gobbi, S., and Rebulla, P. The ethics of cord blood banking in light of ownership, informed consent, and solidarity. Cell Preserv Technol 4, 91, 2006.
100. Samanta, A., Samanta, J., and Price, D. Who owns my body - thee or me? The human tissue story continues. Clin Med 4, 327, 2004.
101. Thasler, W.E., Weiss, T.S., Schillhorn, K., Stoll, P.T., Irrgang, B., and Jauch, K.W. Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany. Cell Tissue Bank 4, 49, 2003.
102. Trommelmans, L., Selling, J., and Dierickx, K. A critical assessment of the directive on tissue engineering of the European union. Tissue Eng 13, 667, 2007.
103. Trouet, C. New European guidelines for the use of stored human biological materials in biomedical research. J Med Ethics 30, 99, 2004.
104. Gunning, J. Umbilical cord cell banking - implications for the future. Toxicol Appl Pharmacol 207, 538, 2005.
105. Sanzenbacher, R., Dwenger, A., Schuessler-Lenz, M., Cichutek, K., and Flory, E. European regulation tackles tissue engineering. Nat Biotechnol 25, 1089, 2007.
106. Smith, D.S. The government's role in advancing regenerative medicine and tissue engineering - science, safety, and ethics. Periodontol 2000 41, 16, 2006.
107. Heinonen, M., Oila, O., and Nordstrom, K. Current issues in the regulation of human tissue-engineering products in the European Union. Tissue Eng 11, 1905, 2005.
108. Salter, B. Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe. Regen Med 2, 301, 2007.
109. Williams, G. Patenting of stem cells. Regen Med 1, 697, 2006.
110. Fisk, N.M., Roberts, I.A.G., Markwald, R., and Mironov, V. Can routine commercial cord blood banking be scientifically and ethically justified? PLoS Med 2, 87, 2005.
111. Kurtzberg, J., Lyerly, A.D., and Sugarman, J. Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest 115, 2592, 2005.
112. Moise, K.J., Jr. Umbilical cord stem cells. Obstet Gynecol 106, 1393, 2005.
113. Rebulla, P. Biobanking in the year 2007. Transfus Med Hemother 34, 286, 2007.
114. Thiel, G.T. 40 projects in stem cell research, tissue engineering, tolerance induction and more (NRP46 "Implants and Transplants" 1999-2006). Swiss Med Wkly 137 Suppl 155, 3S, 2007.
115. Madeddu, P., Emanueli, C., Spillmann, F., Meloni, M., Bouby, N., Richer, C., Alhenc-Gelas, F., Van Weel, V., Eefting, D., Quax, P.H., Hu, Y., Xu, Q., Hemdahl, A.L., van Golde, J., Huijberts, M., de Lussaret, Q., Struijker Baudier, H., Couffinhal, T., Duplaa, C., Chimenti, S., Staszewsky, L., Latini, R., Baumans, V., and Levy, B.I. Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems. Vascul Pharmacol 45, 281, 2006.
116. Nordgren, A. Moral imagination in tissue engineering research on animal models. Biomaterials 25, 1723, 2004.
117. de Brugerolle, A. SkinEthic Laboratories, a company devoted to develop and produce in vitro alternative methods to animal use. ALTEX 24, 167, 2007.
118. Sartipy, P., Björquist, P., Strehl, R., and Hyllner, J. The application of human embryonic stem cell technologies to drug discovery. Drug Discov Today 12, 688, 2007.
119. Sladowski, D., Combes, R., van der Valk, J., Nawrot, I., and Gut, G. ESTIV questionnaire on the acquisition and use of primary human cells and tissue in toxicology. Toxicol In Vitro 19, 1009, 2005.
120. Heng, B.C., Hong, Y.H., and Cao, T. Modulating gene expression in stem cells without recombinant DNA and permanent genetic modification. Cell Tissue Res 321, 147, 2005.
121. Kang, K.A. Tissue engineering as a subdivision of bioprocess engineering: reparative tissue engineering as a subspecialty of tissue engineering. Ann NY Acad Sci 961, 216, 2002.
122. Minger, S. Interspecies SCNT-derived human embryos: a new way forward for regenerative medicine. Regen Med 2, 103, 2007.
123. Steindler, D.A. Stem cells, regenerative medicine, and animal models of disease. ILAR J 48, 323, 2007.
124. Ebbesen, M., and Jensen, T.G. Nanomedicine: techniques, potentials, and ethical implications. J Biomed Biotechnol 2006, 1, 2006.
125. Mazhari, R., and Hare, J.M. Advances in cell-based therapy for structural heart disease. Prog Cardiovasc Dis 49, 387, 2007.
126. Williams, D. A registry for tissue engineering clinical trials. Med Device Technol 17, 8, 2006.
127. Yoo, M.Y. Government regulations on cellular therapy and proposed approach related with these products by KFDA. Yonsei Med J 45 Suppl, 5, 2004.
128. Satava, R.M. Biomedical, ethical, and moral issues being forced by advanced medical technologies. Proc Am Philos Soc 147, 246, 2003.
129. de Grey, A. Strategies for engineered negligible senescence - why genuine control of aging may be foreseeable: preface. Ann NY Acad Sci 1019, xv, 2004.
130. Mauron, A. The choosy reaper. EMBO Rep 6, 67, 2005.
131. Stock, G. From regenerative medicine to human design: what are we really afraid of? DNA Cell Biol 22, 679, 2003.
132. Thacker, E. Bio-X: removing bodily contingency in regenerative medicine. J Med Humanit 23, 239, 2002.
133. Chan, S., and Harris, J. Cognitive regeneration or enhancement: the ethical issues. Regen Med 1, 361, 2006.
134. Metallo, C.M., Azarin, S.M., Lin, J., de Pablo, J.J., and Palecek, S.P. Engineering tissue from human embryonic stem cells. J Cell Mol Med 12, 709, 2008.
135. Inanç, B., Elçin, A.E., Unsal, E., Balos, K., Parlar, A., and Elçin, Y.M. Differentiation of human embryonic stem cells on periodontal ligament fibroblasts in vitro. Artif Organs 32, 100, 2008.
136. Jukes, J.M., Moroni, L., van Blitterswijk, C.A., and de Boer, J. Critical steps toward a tissue-engineered cartilage implant using embryonic stem cells. Tissue Eng Part A 14, 135, 2008.
137. Tremoleda, J.L., Forsyth, N.R., Khan, N.S., Wojtacha, D., Christodoulou, I., Tye, B.J., Racey, S.N., Collishaw, S., Sottile, V., Thomson, A.J., Simpson, A.H., Noble, B.S., and McWhir, J. Bone tissue formation from human embryonic stem cells in vivo. Cloning Stem Cells 10, 119, 2008.
138. French, A.J., Adams, C.A., Anderson, L.S., Kitchen, J.R., Hughes, M.R., and Wood, S.W. Development of human cloned blastocysts following somatic cell nuclear transfer (SCNT) with adult fibroblasts. Stem Cells 26, 485, 2008.
139. Atala, A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 1, 83, 2007.
140. Vajta, G. Somatic cell nuclear transfer in its first and second decades: successes, setbacks, paradoxes and perspectives. Reprod Biomed Online 15, 582, 2007.
141. Gordijn, B. 2006. Medical Utopias. Ethical Reflections about Emerging Medical Technologies. Leuven: Peeters, 2006.
142. Horstman, K. From laboratory to practice: learning about normative issues. In: Doorn, M., ed. Converging Technologies. The Hague: STT, 2005, pp. 134-155.
143. Trommelmans, L., Selling, J., and Dierickx, K. Ethical Issues in Tissue Engineering. Leuven: European Ethical-Legal Papers No. 7, 2007.
144. Bauer, K., Taub, S., and Parsi, K. Ethical issues in tissue banking for research: a brief review of existing organizational policies. Theor Med Bioeth 25, 113, 2004.
145. Nilstun, T., and Hermeren, G. Human tissue samples and ethics: attitudes of the general public in Sweden to biobank research. Med Health Care Philos 9, 81, 2006.
146. Wendler, D. Can we ensure that all research subjects give valid consent? Arch Intern Med 164, 2201, 2004.
147. Jefford, M., and Moore, R. Improvement of informed consent and the quality of consent documents. Lancet Oncol 9, 485, 2008.
148. Hunziker, E.B. Tissue engineering of bone and cartilage. From the preclinical model to the patiënt. Novartis Found Symp 249, 70, 2003.
149. Rashid, S.T., Salacinski, H.J., Hamilton, G., and Seifalian, A.M. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 25, 1627, 2004.
150. Wakeman, D.R., Crain, A.M., and Snyder, E.Y. Large animal models are critical for rationally advancing regenerative therapies. Regen Med 1, 405, 2006.
151. Emanuel, E., Wendler, D., and Grady, Ch. What makes clinical research ethical? JAMA 283, 2701, 2000.
152. Partridge, B., and Hall, W. The search for Methuselah: should we endeavour to increase the maximum human lifespan? EMBO Rep 8, 888, 2007.
153. Stock, G., Callahan, D., and de Grey, A. (mod.). Debate: the ethics of life extension. Rejuvenation Res 10, 407, 2007.
154. McConnel, Ch., and Turner, L. Medicine, ageing and human longevity: the economics and ethics of anti-ageing interventions. EMBO Rep 6, S59, 2005.
155. Caniano, D. Ethical issues in the management of neonatal surgical anomalies. Semin Perinatol 28, 240, 2004.
156. Patrick, Ch. Breast tissue engineering. Annu Rev Biomed Eng 6, 109, 2004.
157. Moseley, T., Zhu, M., and Hedrick, M. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 118, S121, 2006.
158. Miller, F., Brody, H., and Chung, K. Cosmetic surgery and the internal morality of medicine. Camb Q Healthc Ethics 9, 353, 2000.
159. Little, M. Cosmetic surgery, suspect norms, and the ethics of complicity. In: Parens, E., ed. Enhancing Human Traits. Washington, DC: Georgetown University Press, pp. 162-176, 2000.